Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Atezolizumab + Nab-Paclitaxel & Breast cancer / Mammacarcinoma (TNBC), the European Medicines Agency (EMA) approved Atezolizumab + Nab-paclitaxel / Protein-bound paclitaxel for first‑line treatment of adult patients with unresectable locally advanced or metastatic PD‑L1‑positive (IC ≥1%) Breast cancer / Mammacarcinoma (TNBC), based on the IMpassion130 results (1, 3).
A retrospective data analysis of real-world results showed that the progression-fr…